Inventor
XIAOJUN HAN
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes39%
C07KPeptides35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07DHeterocyclic compounds6%
PatentTitleYear
12,545,716Immunoconjugates and methods202612,285,492Immunoconjugates and methods202512,280,121Immunoconjugates and methods202512,274,754Immunoconjugates and methods202512,268,750Immunoconjugates and methods202512,186,403Immunoconjugates and methods202512,097,241Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides202412,097,242Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides202411,884,6613-substituted propionic acids as aV integrin inhibitors202411,806,405Immunoconjugates and methods202311,364,281Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof202211,185,570Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to BRISTOL MYERS SQUIBB CO (5)· patent assignee history
2021–2026Based in US· patent location history
2023Patents assigned to ZENO MAN INC (1)· patent assignee history
2025–2026Patents assigned to IMMUNOME INC (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNOME INC | 6 | 2025–2026 |
| BRISTOL MYERS SQUIBB CO | 5 | 2021–2024 |
| ZENO MAN INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2021–2026 |